repository	study_title	disease_diagnosis	study_group_description	sequences	lab_name	tissue	pcr_target_locus	cell_subset	cell_phenotype	pub_ids	study_id	subject_id	sample_id	template_class	sequencing_platform	repertoire_id	repertoire_name	repertoire_description	study_type	study_type_id	study_description	inclusion_exclusion_criteria	grants	collected_by	lab_address	submitted_by	keywords_study	synthetic	species	species_id	organism	organism_id	sex	age	age_min	age_max	age_unit	age_unit_id	age_event	ancestry_population	ethnicity	race	strain_name	linked_subjects	link_type	disease_diagnosis_id	disease_length	disease_stage	prior_therapies	immunogen	intervention	medical_history	sample_processing_id	sample_type	tissue_id	anatomic_site	disease_state_sample	collection_time_point_relative	collection_time_point_reference	biomaterial_provider	tissue_processing	cell_subset_id	cell_species	cell_species_id	single_cell	cell_number	cells_per_reaction	cell_storage	cell_quality	cell_isolation	cell_processing_protocol	template_quality	template_amount	library_generation_method	library_generation_protocol	library_generation_kit_version	forward_pcr_primer_target_location	reverse_pcr_primer_target_location	complete_sequences	physical_linkage	sequencing_run_id	total_reads_passing_qc_filter	sequencing_facility	sequencing_run_date	sequencing_kit	file_type	filename	read_direction	read_length	paired_filename	paired_read_direction	paired_read_length	data_processing_id	primary_annotation	software_versions	paired_reads_assembly	quality_thresholds	primer_match_cutoffs	collapsing_method	data_processing_protocols	data_processing_files	germline_database	analysis_provenance_id
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	617111	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000014	ADIR0000014_TCRB	DNA	Illumina	5f4c16a983a8226b3dd8db57	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	male	 	43	43	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	 	Recovered	 	 	 	IgA Nephropathy, Coronary artery disease	5f4c16a983a8226b3dd8db57	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	45 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	617111	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16a983a8226b3dd8db57	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIR0000014_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	868205	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000086	ADIR0000086_TCRB	DNA	Illumina	5f4c16ab83a8226b3dd8db59	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	35	35	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	 	Recovered	 	 	 	 	5f4c16ab83a8226b3dd8db59	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	48 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	868205	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16ab83a8226b3dd8db59	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIR0000086_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	366964	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000093	ADIR0000093_TCRB	DNA	Illumina	5f4c16ad83a8226b3dd8db5a	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	38	38	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	 	Acute	 	 	 	 	5f4c16ad83a8226b3dd8db5a	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	10 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	366964	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16ad83a8226b3dd8db5a	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIR0000093_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	791145	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000023	ADIRP0000023_TCRB	DNA	Illumina	5f4c16ae83a8226b3dd8db5b	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	31	31	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	20 d	Recovered	 	 	 	 	5f4c16ae83a8226b3dd8db5b	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	62 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	791145	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16ae83a8226b3dd8db5b	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000023_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	855812	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000036	ADIRP0000036_TCRB	DNA	Illumina	5f4c16af83a8226b3dd8db5c	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	male	 	32	32	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	 	Recovered	 	 	 	 	5f4c16af83a8226b3dd8db5c	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	62 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	855812	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16af83a8226b3dd8db5c	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000036_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	580604	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000045	ADIRP0000045_TCRB	DNA	Illumina	5f4c16b083a8226b3dd8db5d	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	27	27	year	UO:0000036	Sample Collection	 	 	Middle Eastern	 	 	 	DOID:0080600	21 d	Recovered	 	 	 	 	5f4c16b083a8226b3dd8db5d	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	53 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	580604	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16b083a8226b3dd8db5d	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000045_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	721300	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000052	ADIRP0000052_TCRB	DNA	Illumina	5f4c16b183a8226b3dd8db5e	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	male	 	40	40	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	15 d	Recovered	 	 	 	 	5f4c16b183a8226b3dd8db5e	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	16 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	721300	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16b183a8226b3dd8db5e	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000052_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	1043516	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000057	ADIRP0000057_TCRB	DNA	Illumina	5f4c16b283a8226b3dd8db5f	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	49	49	year	UO:0000036	Sample Collection	 	 	Mixed racial group	 	 	 	DOID:0080600	 	Acute	 	 	 	Asthma	5f4c16b283a8226b3dd8db5f	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	30 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	1043516	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16b283a8226b3dd8db5f	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000057_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	548708	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000066	ADIRP0000066_TCRB	DNA	Illumina	5f4c16b383a8226b3dd8db60	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	22	22	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	10 d	Recovered	 	 	 	 	5f4c16b383a8226b3dd8db60	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	62 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	548708	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16b383a8226b3dd8db60	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000066_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	613822	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000067	ADIRP0000067_TCRB	DNA	Illumina	5f4c16b383a8226b3dd8db61	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	33	33	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	40 d	Recovered	 	 	 	 	5f4c16b383a8226b3dd8db61	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	37 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	613822	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16b383a8226b3dd8db61	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000067_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	819078	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000106	ADIRP0000106_TCRB	DNA	Illumina	5f4c16b583a8226b3dd8db63	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	41	41	year	UO:0000036	Sample Collection	 	 	Hispanic	 	 	 	DOID:0080600	28 d	Recovered	 	 	 	Hypothyroidism, Asthma	5f4c16b583a8226b3dd8db63	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	43 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	819078	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16b583a8226b3dd8db63	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000106_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	966188	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000117	ADIRP0000117_TCRB	DNA	Illumina	5f4c16b783a8226b3dd8db65	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	47	47	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	 	Acute	Plaquenil - prednisone	 	 	Juvenile rheumatoid arthritis, Temporal lobe epilepsy, Asthma	5f4c16b783a8226b3dd8db65	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	19 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	966188	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16b783a8226b3dd8db65	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000117_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	1196398	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000120	ADIRP0000120_TCRB	DNA	Illumina	5f4c16b883a8226b3dd8db66	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	23	23	year	UO:0000036	Sample Collection	 	 	Black or African American	 	 	 	DOID:0080600	7 d	Recovered	 	 	 	 	5f4c16b883a8226b3dd8db66	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	33 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	1196398	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16b883a8226b3dd8db66	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000120_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	649670	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000129	ADIRP0000129_TCRB	DNA	Illumina	5f4c16b983a8226b3dd8db67	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	38	38	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	 	Recovered	Imuran	 	 	Dermatomyocititis- morphea, Crohn's disease, Rheumatoid arthritis, Scleroder	5f4c16b983a8226b3dd8db67	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	56 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	649670	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16b983a8226b3dd8db67	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000129_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	42576	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000137	ADIRP0000137_TCRB	DNA	Illumina	5f4c16ba83a8226b3dd8db68	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	33	33	year	UO:0000036	Sample Collection	 	 	Mixed racial group	 	 	 	DOID:0080600	4 d	Recovered	 	 	 	 	5f4c16ba83a8226b3dd8db68	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	43 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	42576	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16ba83a8226b3dd8db68	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000137_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	901858	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000141	ADIRP0000141_TCRB	DNA	Illumina	5f4c16bb83a8226b3dd8db69	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	29	29	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	10 d	Recovered	 	 	 	Asthma	5f4c16bb83a8226b3dd8db69	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	42 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	901858	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16bb83a8226b3dd8db69	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000141_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	600708	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000174	ADIRP0000174_TCRB	DNA	Illumina	5f4c16bc83a8226b3dd8db6a	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	male	 	41	41	year	UO:0000036	Sample Collection	 	 	Middle Eastern European	 	 	 	DOID:0080600	11 d	Recovered	 	 	 	 	5f4c16bc83a8226b3dd8db6a	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	30 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	600708	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16bc83a8226b3dd8db6a	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000174_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	601841	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000190	ADIRP0000190_TCRB	DNA	Illumina	5f4c16bd83a8226b3dd8db6c	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	37	37	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	8 d	Recovered	 	 	 	Papillary Thyroid Cancer (recovered)	5f4c16bd83a8226b3dd8db6c	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	75 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	601841	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16bd83a8226b3dd8db6c	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000190_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	810630	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000247	ADIRP0000247_TCRB	DNA	Illumina	5f4c16be83a8226b3dd8db6d	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	male	 	58	58	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	7 d	Recovered	 	 	 	 	5f4c16be83a8226b3dd8db6d	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	62 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	810630	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16be83a8226b3dd8db6d	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000247_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	306716	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000251	ADIRP0000251_TCRB	DNA	Illumina	5f4c16bf83a8226b3dd8db6e	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	56	56	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	15 d	Recovered	 	 	 	Heart disease	5f4c16bf83a8226b3dd8db6e	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	92 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	306716	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16bf83a8226b3dd8db6e	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000251_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	1047920	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000252	ADIRP0000252_TCRB	DNA	Illumina	5f4c16c083a8226b3dd8db6f	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	28	28	year	UO:0000036	Sample Collection	 	 	Asian or Pacific Islander	 	 	 	DOID:0080600	14 d	Recovered	 	 	 	 	5f4c16c083a8226b3dd8db6f	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	48 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	1047920	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16c083a8226b3dd8db6f	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000252_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	1110928	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000289	ADIRP0000289_TCRB	DNA	Illumina	5f4c16c283a8226b3dd8db71	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	28	28	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	 	Acute	 	 	 	 	5f4c16c283a8226b3dd8db71	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	55 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	1110928	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16c283a8226b3dd8db71	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000289_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	710635	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000292	ADIRP0000292_TCRB	DNA	Illumina	5f4c16c383a8226b3dd8db72	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	male	 	55	55	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	 	Recovered	 	 	 	 	5f4c16c383a8226b3dd8db72	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	50 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	710635	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16c383a8226b3dd8db72	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000292_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	572133	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000341	ADIRP0000341_TCRB	DNA	Illumina	5f4c16c483a8226b3dd8db73	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	66	66	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	 	Recovered	 	 	 	 	5f4c16c483a8226b3dd8db73	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	60 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	572133	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16c483a8226b3dd8db73	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000341_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	413296	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000342	ADIRP0000342_TCRB	DNA	Illumina	5f4c16c583a8226b3dd8db74	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	59	59	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	 	Recovered	 	 	 	 	5f4c16c583a8226b3dd8db74	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	14 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	413296	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16c583a8226b3dd8db74	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000342_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	892792	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000347	ADIRP0000347_TCRB	DNA	Illumina	5f4c16c683a8226b3dd8db75	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	37	37	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	8 d	Recovered	 	 	 	 	5f4c16c683a8226b3dd8db75	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	32 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	892792	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16c683a8226b3dd8db75	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000347_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	285112	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000355	ADIRP0000355_TCRB	DNA	Illumina	5f4c16c783a8226b3dd8db77	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	54	54	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	 	Recovered	 	 	 	Facial skin cancer, Asthma	5f4c16c783a8226b3dd8db77	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	54 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	285112	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16c783a8226b3dd8db77	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000355_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	899701	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000356	ADIRP0000356_TCRB	DNA	Illumina	5f4c16c883a8226b3dd8db78	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	23	23	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	 	Recovered	 	 	 	Asthma	5f4c16c883a8226b3dd8db78	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	44 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	899701	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16c883a8226b3dd8db78	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000356_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	1026076	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000357	ADIRP0000357_TCRB	DNA	Illumina	5f4c16c983a8226b3dd8db79	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	male	 	24	24	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	 	Recovered	Goldbond Psoriasis Cream	 	 	Psoriasis, Asthma	5f4c16c983a8226b3dd8db79	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	44 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	1026076	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16c983a8226b3dd8db79	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000357_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	1031079	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000362	ADIRP0000362_TCRB	DNA	Illumina	5f4c16ca83a8226b3dd8db7a	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	51	51	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	 	Recovered	 	 	 	Multiple sclerosis, Pre diabetic	5f4c16ca83a8226b3dd8db7a	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	39 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	1031079	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16ca83a8226b3dd8db7a	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000362_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	979588	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000376	ADIRP0000376_TCRB	DNA	Illumina	5f4c16cb83a8226b3dd8db7b	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	35	35	year	UO:0000036	Sample Collection	 	 	Indian- Irish- French- polish	 	 	 	DOID:0080600	15 d	Recovered	 	 	 	 	5f4c16cb83a8226b3dd8db7b	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	67 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	979588	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16cb83a8226b3dd8db7b	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000376_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	748720	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000387	ADIRP0000387_TCRB	DNA	Illumina	5f4c16cc83a8226b3dd8db7c	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	male	 	60	60	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	4 d	Recovered	 	 	 	Hypertension	5f4c16cc83a8226b3dd8db7c	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	38 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	748720	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16cc83a8226b3dd8db7c	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000387_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	764789	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000392	ADIRP0000392_TCRB	DNA	Illumina	5f4c16cc83a8226b3dd8db7d	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	48	48	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	 	Recovered	 	 	 	 	5f4c16cc83a8226b3dd8db7d	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	62 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	764789	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16cc83a8226b3dd8db7d	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000392_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	680523	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000422	ADIRP0000422_TCRB	DNA	Illumina	5f4c16cd83a8226b3dd8db7e	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	27	27	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	 	Acute	Inhaler, Albuterol	 	 	 	5f4c16cd83a8226b3dd8db7e	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	58 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	680523	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16cd83a8226b3dd8db7e	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000422_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	645783	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000423	ADIRP0000423_TCRB	DNA	Illumina	5f4c16ce83a8226b3dd8db7f	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	32	32	year	UO:0000036	Sample Collection	 	 	Asian or Pacific Islander	 	 	 	DOID:0080600	 	Recovered	 	 	 	 	5f4c16ce83a8226b3dd8db7f	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	49 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	645783	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16ce83a8226b3dd8db7f	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000423_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	674338	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000439	ADIRP0000439_TCRB	DNA	Illumina	5f4c16cf83a8226b3dd8db80	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	male	 	29	29	year	UO:0000036	Sample Collection	 	 	Asian or Pacific Islander	 	 	 	DOID:0080600	 	Acute	 	 	 	 	5f4c16cf83a8226b3dd8db80	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	13 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	674338	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16cf83a8226b3dd8db80	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000439_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	662793	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000499	ADIRP0000499_TCRB	DNA	Illumina	5f4c16d083a8226b3dd8db82	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	male	 	56	56	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	10 d	Recovered	 	 	 	Asthma	5f4c16d083a8226b3dd8db82	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	41 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	662793	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16d083a8226b3dd8db82	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000499_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	947304	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000511	ADIRP0000511_TCRB	DNA	Illumina	5f4c16d183a8226b3dd8db83	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	male	 	29	29	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	21 d	Recovered	 	 	 	 	5f4c16d183a8226b3dd8db83	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	11 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	947304	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16d183a8226b3dd8db83	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000511_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	725254	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000539	ADIRP0000539_TCRB	DNA	Illumina	5f4c16d283a8226b3dd8db84	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	43	43	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	3 d	Recovered	 	 	 	Hashimoto's thyroiditis	5f4c16d283a8226b3dd8db84	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	57 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	725254	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16d283a8226b3dd8db84	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000539_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	765042	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000555	ADIRP0000555_TCRB	DNA	Illumina	5f4c16d383a8226b3dd8db85	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	male	 	48	48	year	UO:0000036	Sample Collection	 	 	 	 	 	 	DOID:0080600	14 d	Recovered	 	 	 	 	5f4c16d383a8226b3dd8db85	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	51 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	765042	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16d383a8226b3dd8db85	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000555_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	409185	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000570	ADIRP0000570_TCRB	DNA	Illumina	5f4c16d483a8226b3dd8db86	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	male	 	65	65	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	14 d	Recovered	 	 	 	 	5f4c16d483a8226b3dd8db86	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	50 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	409185	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16d483a8226b3dd8db86	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000570_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	984502	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000618	ADIRP0000618_TCRB	DNA	Illumina	5f4c16d583a8226b3dd8db87	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	31	31	year	UO:0000036	Sample Collection	 	 	Mixed racial group	 	 	 	DOID:0080600	 	Acute	 	 	 	Rheumatoid arthritis, Asthma	5f4c16d583a8226b3dd8db87	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	29 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	984502	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16d583a8226b3dd8db87	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000618_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	1152643	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000623	ADIRP0000623_TCRB	DNA	Illumina	5f4c16d583a8226b3dd8db88	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	59	59	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	20 d	Recovered	 	 	 	Asthma	5f4c16d583a8226b3dd8db88	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	34 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	1152643	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16d583a8226b3dd8db88	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000623_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	650861	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000709	ADIRP0000709_TCRB	DNA	Illumina	5f4c16d783a8226b3dd8db8a	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	41	41	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	 	Acute	 	 	 	Ulcerative colitis	5f4c16d783a8226b3dd8db8a	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	30 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	650861	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16d783a8226b3dd8db8a	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000709_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	594037	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000710	ADIRP0000710_TCRB	DNA	Illumina	5f4c16d883a8226b3dd8db8b	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	36	36	year	UO:0000036	Sample Collection	 	 	Hispanic	 	 	 	DOID:0080600	30 d	Recovered	 	 	 	 	5f4c16d883a8226b3dd8db8b	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	63 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	594037	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16d883a8226b3dd8db8b	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000710_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	833555	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000730	ADIRP0000730_TCRB	DNA	Illumina	5f4c16d983a8226b3dd8db8c	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	54	54	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	 	Acute	Prednisone	 	 	Hypertension	5f4c16d983a8226b3dd8db8c	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	63 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	833555	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16d983a8226b3dd8db8c	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000730_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	674035	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000752	ADIRP0000752_TCRB	DNA	Illumina	5f4c16db83a8226b3dd8db8e	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	40	40	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	 	Acute	 	 	 	Asthma	5f4c16db83a8226b3dd8db8e	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	52 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	674035	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16db83a8226b3dd8db8e	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000752_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	503659	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000837	ADIRP0000837_TCRB	DNA	Illumina	5f4c16dc83a8226b3dd8db90	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	55	55	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	22 d	Recovered	 	 	 	 	5f4c16dc83a8226b3dd8db90	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	50 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	503659	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16dc83a8226b3dd8db90	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000837_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	475090	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000868	ADIRP0000868_TCRB	DNA	Illumina	5f4c16dd83a8226b3dd8db91	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	58	58	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	16 d	Recovered	 	 	 	Hashimoto's thyroiditis	5f4c16dd83a8226b3dd8db91	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	61 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	475090	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16dd83a8226b3dd8db91	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000868_TCRB.tsv"]	Adaptive germline database	 
AIRR COVID-19	COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.	COVID-19	Case	935205	Adaptive Biotechnologies	blood	TRB	 	 	DOI: 10.21417/ADPT2020COVID	ImmuneCODE-COVID-Release-002: COVID-19-Adaptive	ADIRP0000875	ADIRP0000875_TCRB	DNA	Illumina	5f4c16de83a8226b3dd8db92	 	 	Study	NCIT:C63536	We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.	 	Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	1551 Eastlake Ave E, Seattle, WA, US	Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com	["contains_tcr"]		Homo sapiens	NCBITAXON:9606	 	 	female	 	36	36	year	UO:0000036	Sample Collection	 	 	Caucasian	 	 	 	DOID:0080600	 	Recovered	 	 	 	Asthma	5f4c16de83a8226b3dd8db92	Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.	UBERON:0000178	 	 	41 d	Diagnosis	Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs	 	 	Homo sapiens	NCBITAXON:9606		 	 	 	 	 	 	 	 	PCR	Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. 	v4	TRBV	TRBJ	partial	nan	 	935205	Adaptive Biotechnologies	 	 immunoSEQ Assay v4	 	 	 	 	 	 	 	5f4c16de83a8226b3dd8db92	1	immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)	 	 	 	 	TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.	["ADIRP0000875_TCRB.tsv"]	Adaptive germline database	 
